Plea Bargaining in Drug Cases: Balancing DOJ Guidelines and Judicial Discretion

The Supreme Court's 2022 decision in Cereza v. Suarez (G.R. No. 242722) clarifies a crucial question for criminal defense: when an accused person charged with a drug offense seeks to plea bargain, whose rules apply—the Department of Justice's internal guidelines or the Supreme Court's own Plea Bargaining Framework? The ruling provides important guidance for trial courts, prosecutors, and accused persons navigating plea bargaining under the Comprehensive Dangerous Drugs Act.

The Case Before the Court

Six individuals were charged with violating Section 13 of Republic Act No. 9165—possession of dangerous drugs during parties, social gatherings, or meetings—after a single sachet of shabu weighing 0.07 gram was recovered. They initially pleaded not guilty but later moved to withdraw their pleas and enter into plea bargaining.

The trial court allowed them to plead guilty to a lesser offense under Section 11, paragraph 3 of R.A. No. 9165, applying DOJ Circular No. 027. That offense carries a penalty of 12 years and one day to 20 years, plus a fine of P300,000 to P400,000. The accused sought a more favorable deal: pleading guilty to Section 12 (possession of drug paraphernalia), which carries only six months and one day to four years and a fine of P10,000 to P50,000, as allowed under the Supreme Court's A.M. No. 18-03-16-SC.

The Core Issues

The petitioners raised several constitutional challenges against DOJ Circular No. 027. They argued that the circular encroached on the Supreme Court's exclusive rule-making power because it allowed plea bargaining for offenses not listed in A.M. No. 18-03-16-SC and imposed higher penalties than the Court's framework. They also claimed that requiring a drug dependency assessment before the prosecution consents to a plea bargain violated their right to privacy and against self-incrimination.

The Supreme Court's Ruling

The Court rejected the argument that DOJ Circular No. 027 is unconstitutional. Citing its earlier ruling in Sayre v. Xenos, the Court explained that the circular does not repeal, alter, or modify the Plea Bargaining Framework. It serves merely as an internal guideline for prosecutors before they give their consent to proposed plea bargains.

The Court emphasized that plea bargaining requires the consent of the prosecutor, who acts as an officer of the executive department. It is only appropriate for the DOJ to issue guidelines to govern how prosecutors exercise that discretion. The circular does not encroach on judicial power because the final decision to accept or reject a plea bargain still rests with the trial court.

Guidelines for Trial Courts

The Court reiterated the guidelines from People v. Montierro that trial judges must observe in drug cases. Key points include:

• Plea bargaining offers must be initiated by a formal written motion from the accused.
• The lesser offense must be necessarily included in the offense charged.
• Upon receipt of a compliant proposal, the judge shall order a drug dependency assessment.
• Courts must exercise sound discretion and cannot automatically approve plea bargains, even with prosecution consent.
• Plea bargaining should be denied if the offender is a recidivist, habitual offender, known drug addict, or has undergone rehabilitation but relapsed, or when evidence of guilt is strong.

Significantly, the Court held that judges may overrule a prosecutor's objection if it is based solely on inconsistency with DOJ internal guidelines, provided the proposal conforms to the Court's framework.

The Drug Dependency Assessment

On the constitutional challenge to the drug dependency assessment requirement, the Court found no violation. Citing Dela Cruz v. People, it noted that drug tests are already permitted for persons apprehended for violations under Article II of R.A. No. 9165. The assessment serves as a legitimate basis for the court to evaluate whether an accused is suitable for the shorter incarceration that plea bargaining entails.

What Went Wrong in This Case

The Court found that the trial court simply applied DOJ Circular No. 027 without properly assessing the accused's qualifications and the evidence on record. The judge failed to consider the character of the accused—whether they were recidivists, habitual offenders, or otherwise unsuitable for plea bargaining. The case was remanded for the trial court to apply the Montierro guidelines properly.

Practical Takeaways

• Plea bargaining is not a demandable right. It requires both prosecutorial consent and judicial approval, and courts must exercise sound discretion based on the evidence and the accused's character.
• DOJ Circular No. 027 does not override the Supreme Court's framework. It guides prosecutors internally, but judges may overrule objections based solely on DOJ guidelines when the proposal conforms to A.M. No. 18-03-16-SC.
• A drug dependency assessment is a legitimate requirement. It helps courts evaluate whether an accused is suitable for the reformation that plea bargaining contemplates.
• Trial courts must do more than rubber-stamp plea bargains. They must assess the accused's qualifications and the strength of the prosecution's evidence before granting a motion to withdraw plea.
• The applicable framework may change over time. The Court noted that A.M. No. 18-03-16-SC was later amended to include Section 13 offenses, showing that the rules continue to evolve.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.